Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Kidney International Reports
|
December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
Edwin Wong, Carla Nester, Teresa Cavero, et al.
American Journal of Nephrology
|
November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D Podos, Howard Trachtman, Gerald B Appel, et al.
Annals of the Rheumatic Diseases
|
July 31, 2016
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Eli M Miloslavsky, Ray P Naden, Johannes W J Bijlsma, et al.
American Journal of Nephrology
|
November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
Carla Nester, Gerald B Appel, Andrew S Bomback, et al.
Kidney International
|
November 12, 2020
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring
Meryl Waldman, Maria Jose Soler, Clara García-Carro, et al.
Kidney International
|
December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
Fadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Annals of the Rheumatic Diseases
|
August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Kidney International
|
May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
Simon A Carter, Liz Lightstone, Daniel Cattran, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Kidney International Reports
|
December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
Edwin Wong, Carla Nester, Teresa Cavero, et al.
American Journal of Nephrology
|
November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D Podos, Howard Trachtman, Gerald B Appel, et al.
Annals of the Rheumatic Diseases
|
July 31, 2016
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Eli M Miloslavsky, Ray P Naden, Johannes W J Bijlsma, et al.
American Journal of Nephrology
|
November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
Carla Nester, Gerald B Appel, Andrew S Bomback, et al.
Kidney International
|
November 12, 2020
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring
Meryl Waldman, Maria Jose Soler, Clara García-Carro, et al.
Kidney International
|
December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
Fadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Annals of the Rheumatic Diseases
|
August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Kidney International
|
May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
Simon A Carter, Liz Lightstone, Daniel Cattran, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Page
of 12